INS and pancreatic neoplasm: We analyzed the infiltration of pancreatic cancer cells into pancreatic islets via double-immunolabeling of human pancreatic cancer tissues with insulin or glucagon and the pancreatic cancer cell marker cytokeratin 19 (CK-19) or Mucin-1 (MUC1).